ƽ

STEMdiff™ Cardiomyocyte Maintenance Kit

Medium for long-term maintenance of human PSC-derived cardiomyocytes

STEMdiff™ Cardiomyocyte Maintenance Kit

Medium for long-term maintenance of human PSC-derived cardiomyocytes

Catalog #
(Select a product)
Medium for long-term maintenance of human PSC-derived cardiomyocytes
Request Pricing Request Pricing

Product Advantages


  • Supports long-term maintenance of hPSC-derived cardiomyocytes for one month or longer

  • Maintain functionality for downstream applications and analysis

  • Provided in a simple 2-component format for ease-of-use

What's Included

  • STEMdiff™ Cardiomyocyte Maintenance Basal Medium, 490 mL
  • STEMdiff™ Cardiomyocyte Maintenance Supplement (50X), 10 mL

Overview

STEMdiff™ Cardiomyocyte Maintenance Kit can be used for long-term maintenance of human pluripotent stem cell (PSC)-derived cardiomyocytes for one month or longer. The functional capacity of hPSC-derived cardiomyocytes is retained for downstream applications and analysis. This kit is compatible with cardiomyocytes generated using STEMdiff™ Ventricular Cardiomyocyte Differentiation Kit (Catalog #05010) or STEMdiff™ Atrial Cardiomyocyte Differentiation Kit (Catalog #100-0215).
Subtype
Specialized Media
Cell Type
Cardiomyocytes, PSC-Derived
Species
Human
Application
Cell Culture, Maintenance
Brand
STEMdiff
Area of Interest
Stem Cell Biology
Formulation Category
Serum-Free

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
05020
Lot #
All
Language
English
Document Type
Product Name
Catalog #
05020
Lot #
All
Language
English
Document Type
Product Name
Catalog #
05020
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (7)

Brochure
Scientific Poster
Scientific Poster
Scientific Poster
Scientific Poster

Publications (1)

Propionic Acidemia?Induced Proarrhythmic Electrophysiological Alterations in Human iPSC?Derived Cardiomyocytes Journal of Inherited Metabolic Disease 2025 Apr

Abstract

ABSTRACTPropionic acidemia (PA) is a metabolic disorder caused by a deficiency of the mitochondrial enzyme propionyl?CoA carboxylase (PCC) due to mutations in the PCCA or PCCB genes, which encode the two PCC subunits. PA may lead to several types of cardiomyopathy and has been linked to cardiac electrical abnormalities such as QT interval prolongation, life?threatening arrhythmias, and sudden cardiac death. To gain insights into the mechanisms underlying PA?induced proarrhythmia, we recorded action potentials (APs) and ion currents using whole?cell patch?clamp in ventricular?like induced pluripotent stem cells?derived cardiomyocytes (hiPSC?CMs) from a PA patient carrying two pathogenic mutations in the PCCA gene (p.Cys616_Val633del and p.Gly477Glufs*9) (PCCA cells) and from a healthy subject (healthy cells). In cells driven at 1?Hz, PCC deficiency increased the latency and prolonged the AP duration (APD) measured at 20% of repolarization, without modifying resting membrane potential or AP amplitude. Moreover, delayed afterdepolarizations appeared at the end of the repolarization phase in unstimulated and paced PCCA cells. PCC deficiency significantly reduced peak sodium current (I Na) but increased the late I Na (I NaL) component. In addition, L?type Ca2+ current (I CaL) density was reduced, while the inward and outward density of the Na+/Ca2+ exchanger current (I NCX) was increased in PCCA cells compared to healthy ones. In conclusion, our results demonstrate that at the cellular level, PCC deficiency can modify the ion currents controlling cardiac excitability, APD, and intracellular Ca2+ handling, increasing the risk of arrhythmias independently of the progressive late?onset cardiomyopathy induced by PA disease.